The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.50
Bid: 26.00
Ask: 26.45
Change: -0.50 (-1.85%)
Spread: 0.45 (1.731%)
Open: 26.00
High: 27.05
Low: 26.00
Prev. Close: 27.00
SHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Apr 2024 10:12

RNS Number : 3334J
SIG PLC
04 April 2024
 

LEI: 213800VDC1BKJEZ8PV53 4 April 2024

SIG plc

("SIG" or the "Company")

Notification and public disclosure of Exercise of Restricted Share Plan and Deferred Bonus Plan Awards by Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

Exercise of 2021 Restricted Share Plan ("RSP") Awards

On 2 April 2024 Ian Ashton, Chief Financial Officer, exercised nil cost options (the "RSP Options") under the RSP to acquire 975,961 shares of 10 pence each in the capital of the Company ("Shares"). 469,520 Shares were sold on 2 April 2024 to realise funds to settle income tax and national insurance obligations arising on exercise of the RSP Options. The balance of 506,441 Shares were retained by him and are subject to a holding period of two years under the Directors' Remuneration Policy.

Exercise of 2020 Deferred Bonus Plan ("DBP") Awards

In addition, on 2 April 2024 Ian Ashton, Chief Financial Officer, exercised nil cost options (the "DBP Options") under the DBP to acquire 80,128 shares of 10 pence each in the capital of the Company ("Shares"). 37,796 Shares were sold on 2 April 2024 to realise funds to settle income tax and national insurance obligations arising on exercise of the DBP Options. The balance of 42,332 Shares were retained by him and are subject to a holding period of two years under the Directors' Remuneration Policy.

This announcement and the following disclosures are made in accordance with the UK Market Abuse Regulation.  

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ashton

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SIG plc

b)

LEI

213800VDC1BKJEZ8PV53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

 

b)

Nature of the transaction

Exercise of share awards granted on 29 March 2021 under the SIG plc 2020 Restricted Share Plan

c)

Price(s) and volume(s)

Price(s)

 Volume(s)

 

GBP Nil

975,961

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

 

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

 

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s) 

GBP 0.2795

 469,520

d)

Aggregated information

- Aggregated volume

- Price

 Aggregate Price

Aggregate Volume

Aggregate Total

 

GBP 0.2795

 469,520

GBP 131,231

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

London Stock Exchange, Main Market XLON

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ashton

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SIG plc

b)

LEI

213800VDC1BKJEZ8PV53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

 

b)

Nature of the transaction

Exercise of share awards granted on 29 March 2021 under the SIG plc 2018 Deferred Bonus Plan

c)

Price(s) and volume(s)

Price(s)

 Volume(s)

 

GBP Nil

80,128

d)

Aggregated information

- Aggregated volume

- Price

 Not applicable - single transaction

 

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

 

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s) 

GBP 0.2930

 37,796

d)

Aggregated information

- Aggregated volume

- Price

 Aggregate Price

Aggregate Volume

Aggregate Total

 

GBP 0.2930

 37,796

GBP 11,074

e)

Date of the transaction

2 April 2024

f)

Place of the transaction

London Stock Exchange, Main Market XLON

 

Enquiries

SIG plc

Andrew Watkins, Group General Counsel & Company Secretary +44 (0) 0114 285 6300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSSSULELSEFL
Date   Source Headline
12th Apr 20244:01 pmRNSDirector/PDMR Shareholding
4th Apr 202410:12 amRNSDirector/PDMR Shareholding
25th Mar 202410:21 amRNSNotice of AGM
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 202410:12 amRNSDirector/PDMR Shareholding
5th Mar 202412:14 pmRNSAnnual Financial Report
5th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
9th Jan 20247:00 amRNS2023 Full Year Trading Update
1st Dec 20235:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSCapital Markets Event
13th Nov 20239:00 amRNSNotice of Capital Markets Event
13th Oct 20233:51 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ3 Trading Update
25th Sep 20233:56 pmRNSDirectorate Change
9th Aug 20234:58 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSHolding(s) in Company
11th Jul 20234:06 pmRNSHolding(s) in Company
11th Jul 202310:58 amRNSHolding(s) in Company
10th Jul 202311:09 amRNSHolding(s) in Company
5th Jul 20233:15 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSH1 Trading Update
4th May 20232:32 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
31st Mar 202312:47 pmRNSHolding(s) in Company
27th Mar 202310:30 amRNSNotice of AGM
13th Mar 20233:49 pmRNSDirector/PDMR Shareholding
13th Mar 20233:39 pmRNSDirector/PDMR Shareholding
13th Mar 202310:36 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSDirector/PDMR Shareholding
8th Mar 20231:20 pmRNSAnnual Financial Report
8th Mar 20237:01 amRNSDirectorate Changes
8th Mar 20237:00 amRNSFull year results for the year ended 31 Dec 2022
27th Feb 202311:20 amRNSDirector Declaration
1st Feb 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding
8th Apr 20223:28 pmRNSDirector/PDMR Shareholding
8th Apr 20223:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.